Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass

Completed

Conditions studied: Bleeding Marginal Ulcer

In brief

The objective of this study is to identify the incidence rate; describe the risk factors, clinical presentation, and endoscopic treatment; assess the morbidity, mortality, and overall performance of the management of patients with actively bleeding marginal ulcers after Roux-en-Y gastric bypass (RYGB) surgery.

Key facts

Study ID

NCT01040416

Run by

University of California, San Francisco

People needed

45

Starts

2008-12-01

Expected to finish

2009-12-01

Last updated by the study team

2009-12-29

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients status post laparoscopic RYGB surgery with active gastrointestinal hemorrhage secondary to marginal ulcer

You may not qualify if…

• bleeding marginal ulcers after other bariatric procedures
• staple-line bleeding after RYGB
• iron-deficiency anemia (chronic) secondary to non-actively bleeding marginal ulcer after RYGB
• other sources of GI bleeding different from marginal ulcer such as from staple-lines, complicated PUD, and other surgical and medical causes of GI hemorrhage
• missing records and/or unreachable patients with scant information for analysis

Where it is running

• UCSF Fresno Center for Medical Education and Research — Fresno, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.